Mid-Stage Win for Novel IgA Nephropathy Drug

(MedPage Today) -- PHILADELPHIA -- An investigational humanized IgG2 monoclonal antibody reduced proteinuria in adults with immunoglobulin A (IgA) nephropathy at high risk for disease progression despite standard treatments, a randomized phase...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news